Wells Fargo’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $371 | Sell |
113
-1
| -0.9% | -$3 | ﹤0.01% | 5942 |
|
|
2025
Q1 | $318 | Sell |
114
-2
| -2% | -$6 | ﹤0.01% | 5831 |
|
|
2024
Q4 | $2K | Buy |
116
+80
| +222% | +$1.38K | ﹤0.01% | 5687 |
|
|
2024
Q3 | $990 | Buy |
36
+13
| +57% | +$358 | ﹤0.01% | 5716 |
|
|
2024
Q2 | $926 | Sell |
23
-5
| -18% | -$201 | ﹤0.01% | 5714 |
|
|
2024
Q1 | $1.88K | Buy |
28
+17
| +155% | +$1.14K | ﹤0.01% | 5652 |
|
|
2023
Q4 | $1.3K | Buy |
11
+1
| +10% | +$118 | ﹤0.01% | 5726 |
|
|
2023
Q3 | $1.83K | Buy |
10
+1
| +11% | +$183 | ﹤0.01% | 5727 |
|
|
2023
Q2 | $3.42K | Sell |
9
-85
| -90% | -$32.3K | ﹤0.01% | 5823 |
|
|
2023
Q1 | $62.8K | Buy |
94
+87
| +1,243% | +$58.1K | ﹤0.01% | 4765 |
|
|
2022
Q4 | $5.69K | Sell |
7
-2
| -22% | -$1.63K | ﹤0.01% | 5407 |
|
|
2022
Q3 | $9K | Sell |
9
-9
| -50% | -$9K | ﹤0.01% | 5381 |
|
|
2022
Q2 | $15K | Sell |
18
-257
| -93% | -$214K | ﹤0.01% | 5284 |
|
|
2022
Q1 | $425K | Sell |
275
-167
| -38% | -$258K | ﹤0.01% | 4250 |
|
|
2021
Q4 | $793K | Buy |
442
+80
| +22% | +$144K | ﹤0.01% | 4035 |
|
|
2021
Q3 | $1.2M | Buy |
362
+343
| +1,805% | +$1.13M | ﹤0.01% | 3871 |
|
|
2021
Q2 | $84K | Sell |
19
-46
| -71% | -$203K | ﹤0.01% | 5044 |
|
|
2021
Q1 | $315K | Buy |
65
+55
| +550% | +$267K | ﹤0.01% | 4634 |
|
|
2020
Q4 | $18K | Buy |
10
+9
| +900% | +$16.2K | ﹤0.01% | 5634 |
|
|
2020
Q3 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 5824 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5890 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5848 |
|